Lv6
2170 积分 2021-12-14 加入
AJM300 (carotegrast methyl), an oral antagonist of α4-integrin, as induction therapy for patients with moderately active ulcerative colitis: a multicentre, randomised, double-blind, placebo-controlled, phase 3 study
22天前
已完结
HMPL-306 in relapsed or refractory IDH1- and/or IDH2-mutated acute myeloid leukemia: A phase 1 study
23天前
已完结
PROTAC targeted protein degraders: the past is prologue
2个月前
已完结
Opportunities and challenges for targeting HPK1 in cancer immunotherapy
4个月前
已完结
Current strategies for targeting HPK1 in cancer and the barriers to preclinical progress
4个月前
已完结
Trial in Progress: Phase 1/2 Study of Donor-Derived Anti-CD33 Chimeric Antigen Receptor Expressing T Cells (VCAR33) in Patients with Relapsed or Refractory Acute Myeloid Leukemia after Allogeneic Hematopoietic Cell Transplantation
7个月前
已完结
Phase III clinical trial comparing the efficacy and safety of adamgammadex with sugammadex for reversal of rocuronium-induced neuromuscular block
11个月前
已完结
Is adamgammadex the brother of sugammadex or the next generation of reversal agent?
11个月前
已完结
Triple–Hormone-Receptor Agonist Retatrutide for Obesity — A Phase 2 Trial
1年前
已完结
皖公网安备34019202002308
